featured
Long-Term Efficacy and Safety of Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients With ASCVD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
Lancet 2022 Jul 18;[EPub Ahead of Print], BK Kim, SJ Hong, YJ Lee, SJ Hong, KH Yun, BK Hong, JH Heo, SW Rha, YH Cho, SJ Lee, CM Ahn, JS Kim, YG Ko, D Choi, Y Jang, MK HongFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.